NIH Seeks Input on Extramural Harassment Web Form
Published Date: 3/12/2026
Notice
Summary
The NIH wants to keep their Extramural Harassment Web Form going to help people report harassment related to NIH-funded research. They’re asking for public feedback by May 11, 2026, to make sure the form works well and isn’t a hassle. This update won’t cost extra but will keep the tool ready and useful for researchers and staff.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Continued Harassment Reporting Duty
If your institution received NIH grant or cooperative agreement funds in FY2022 or later, the institution must notify NIH within 30 days when a principal investigator or key personnel is removed or disciplined for harassment. The notification must be submitted through the NIH Extramural Harassment Web Form and include the Authorized Organization Representative's name, the individual of concern, a description of concerns, actions taken, and any anticipated impact on NIH-funded award(s). OMB approval is being requested to extend the form for an additional 3 years (OMB #0925-0777; expiration listed as 2026-03-31).
Secure Web Form for Harassment Reports
Researchers, staff, and authorized representatives can use a secure, confidential NIH Extramural Harassment Web Form to report harassment related to NIH-funded research. There are no monetary costs to respond; each submission is estimated to take about 15 minutes, with total estimated annual burden of 60 hours (240 total annual responses: 140 private-sector grant recipients and 100 individuals).
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2026-04790, Advisory Committee on Construction Safety and Health (ACCSH or Committee): Notice of Meetings and Member Appointments
The Secretary of Labor just picked nine new members for the Advisory Committee on Construction Safety and Health (ACCSH). This committee will meet online on March 31 and April 1, 2026, to talk about making construction sites safer. If you work in construction or care about safety rules, now’s the time to share your thoughts by March 20, 2026!
Next: 2026-04792, Hazardous Materials: 2026 Hazardous Materials Safety Research, Development, and Technology Forum
The Pipeline and Hazardous Materials Safety Administration is hosting a fun and important forum from March 31 to April 2, 2026, in the Washington, DC area. This event brings together experts and stakeholders to share research, discuss new safety ideas, and plan future projects to keep hazardous materials transport safer and smarter. If you work with or care about hazardous materials, this is your chance to get involved and help shape the future!